Coloplast AS Profit Margin

The latest profit margin for CLPBY is 8.86% as of June 2026. That compares with 14.62% in the prior-year period — down 39.4% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Coloplast AS's historical trend and sector peers before judging valuation or financial health.

Over the past year, CLPBY's profit margin moved from 14.62% to 8.86% — a 39.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Coloplast AS's valuation or profitability profile.

Against Healthcare companies, CLPBY currently prints 8.86% for profit margin, while the sector average sits near 13.89%. That is roughly 36.2% below the sector mean. Large gaps often invite a closer look at Coloplast AS's growth, margins, and balance sheet.

Profit Margin shows how effectively Coloplast AS converts resources into returns. At 8.86%, CLPBY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 14.62% in the prior-year period — down 39.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CLPBY's profit margin (8.86%), review year-over-year change from 14.62%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.